Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Isotope & RadiationFRA:5IR +1.14%92 5-Year Yield-on-Cost % is 4.40 as of Aug. 28, 2026, which is 9% above its 10-year median of 4.02. GuruFocus rates FRA:5IR with a GF Score™ of 92/100 and a GF Value™ of €1.63. The stock has 5 warning signs investors should review. Among 315 Medical Devices & Instruments companies, China Isotope & Radiation ranks better than 80.32% on this metric.
The historical rank and industry rank for China Isotope & Radiation's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:5IR'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.15 Med: 4.02 Max: 14.02
Current: 4.4
During the past 11 years, China Isotope & Radiation's highest Yield on Cost was 14.02. The lowest was 1.15. And the median was 4.02.
FRA:5IR's 5-Year Yield-on-Cost % is ranked better than 80.32% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs FRA:5IR: 4.40
China Isotope & Radiation (FRA:5IR) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
China Isotope & Radiation 5-Year Yield-on-Cost % Related Terms
FRA:5IR vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, China Isotope & Radiation's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's 5-Year Yield-on-Cost % falls into.
China Isotope & Radiation 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
China Isotope & Radiation (FRA:5IR) has a 5-Year Yield-on-Cost % of 4.40 as of Aug. 28, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on China Isotope & Radiation and its competitors. This is near median its historical median of 4.02. Over the past decade, China Isotope & Radiation's 5-Year Yield-on-Cost % has ranged from 1.15 to 14.02. According to the industry distribution chart, China Isotope & Radiation ranks #62 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 19.7%.
Is China Isotope & Radiation's 5-Year Yield-on-Cost % too high?
China Isotope & Radiation's current 5-Year Yield-on-Cost % of 4.40 is near median its 10-year median of 4.02. Over the past 10 years, this metric has ranged from a low of 1.15 to a high of 14.02. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.43. China Isotope & Radiation's value of 4.40 is 81.1% above this industry median. Based on the distribution chart, China Isotope & Radiation ranks #62 out of 315 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, China Isotope & Radiation has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Isotope & Radiation's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, China Isotope & Radiation ranks #62 out of 315 companies for 5-Year Yield-on-Cost %. This places China Isotope & Radiation in the top 20% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.43. China Isotope & Radiation's value of 4.40 is 81.1% above this benchmark. Historically, China Isotope & Radiation's own 5-Year Yield-on-Cost % has ranged from 1.15 to 14.02 over the past decade. While the company's 10-year median is 4.02 vs. the industry median of 2.43, China Isotope & Radiation has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.43, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Isotope & Radiation's current 5-Year Yield-on-Cost % of 4.40 is 81.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on China Isotope & Radiation and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Isotope & Radiation's current 5-Year Yield-on-Cost % is 4.40, which is near median its own 10-year median of 4.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Isotope & Radiation stock overvalued right now?
China Isotope & Radiation (FRA:5IR) has a current 5-Year Yield-on-Cost % of 4.40. The stock's GF Value™ is €1.63, compared to a current price of €1.77 — trading 8.6% above its estimated fair value. The current 5-Year Yield-on-Cost % is 4.40, which is near median its 10-year median of 4.02 and 81.1% above the Medical Devices & Instruments industry median of 2.43. China Isotope & Radiation's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For China Isotope & Radiation (FRA:5IR), the current 5-Year Yield-on-Cost % is 4.40 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Isotope & Radiation (FRA:5IR) Overvalued in 2026?
Based on GuruFocus' analysis, China Isotope & Radiation stock appears to be overvalued.
The current stock price of €1.77 is trading 8.6% above its estimated GF Value™ of €1.63.
Key valuation signals for FRA:5IR:
5-Year Yield-on-Cost %: 4.40 (near median its 10-year median of 4.02)
GF Value™: €1.63 vs. price of €1.77 (8.6% above fair value)
Industry Position: 81.1% above the Medical Devices & Instruments median (#62 of 315)
No single metric tells the full story. See the FRA:5IR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: (1) nuclear medicine; (2) radioactive source products; (3) irradiation; (4) nuclear medical equipment and related services; and (5) other businesses. Nuclear medicines: manufacturing and sale of a range of imaging diagnostic and therapeutic radio pharmaceuticals imaging, UBT diagnostic kits and test analysers and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
92GF Score
Get the complete analysis for FRA:5IR
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5IR has been successfully added to your 
